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Summary
Partial lipodystrophy (PLD), also known as “Dunnigan-
Kobberling syndrome,” is transmitted as a highly pen-
etrant autosomal dominant disorder that is characterized
by a dramatic absence of adipose tissue in the limbs and
trunk, more evident in females than in males. In contrast,
fat is retained on the face, in retro-orbital space, and at
periserous sites. Associated metabolic abnormalities, in-
cluding insulin resistance, hyperinsulinemia, and dysli-
pidemia, are referred to as “metabolic syndrome X”
(Reaven 1988). Despite the intense interest in the genetic
determinants underlying fat deposition, the genes in-
volved in the lipodystrophic syndromes have not been
identified. We ascertained two multigeneration families,
with a combined total of 18 individuals with PLD, and
performed a genomewide search. We obtained conclu-
sive evidence for linkage of the PLD locus to microsat-
ellite markers on chromosome 1q21 (D1S498, maxi-
mum LOD score 6.89 at recombination fraction .00),
with no evidence of heterogeneity. Haplotype and mul-
tipoint analysis support the location of the PLD locus
within a 21.2-cM chromosomal region that is flanked
by the markers D1S2881 and D1S484. These data rep-
resent an important step in the effort to isolate and char-
acterize the PLD gene. The identification of the gene will
have important implications for the understanding of
both developmental and metabolic aspects of the adi-
pocyte and may prove useful as a single-gene model for
the common metabolic disorder known as “syndrome
X.”
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Introduction
Dunnigan et al. (1974) and Kobberling et al. (1975)
independently described a familial disorder, partial li-
podystrophy (PLD [MIM 151660]), which is character-
ized by the regional absence of subcutaneous adipose
tissue and segregates as an autosomal dominant trait
(Jackson et al. 1997b). Anthropometric evaluation and
cross-sectional imaging demonstrates the presence of fat
in the body cavities and the subcutaneous tissues of the
head and neck but its complete absence from the sub-
cutaneous tissues of the trunk and limbs. Of interest,
skeletal muscle hypertrophy is also present (Jackson et
al. 1997b). A variety of additional features have been
reported, including hyperlipidemia, resistance to the glu-
cose-lowering effects of insulin, and systemic hyperten-
sion (Davidson and Young 1975; Burn and Baraitser
1986; Kobberling and Dunnigan 1986), all of which are
known to be determinants for ischemic heart disease and
stroke. In population-based studies, a low ratio of pe-
ripheral to central obesity has been associated with an
increased risk of cardiovascular disease; this serves to
emphasize the importance of fat distribution in the pre-
disposition to common diseases, in developed countries
(Kahn et al. 1995).
The adipocyte plays a critical role in human metab-
olism (Harris and Crabb 1997). Differences in energy
turnover, both in the basal state and in response to hor-
monal stimulation, have been described between sub-
cutaneous and intra-abdominal fat deposits (Bjorntorp
1996). Although the metabolic pathways for energy cy-
cling have been known for many years, little is known
of the molecular genetic basis of fat-cell regional dis-
tribution.
Attempts to unravel the genetic contribution to com-
mon complex traits such as coronary heart disease re-
main a significant challenge. One promising strategy uses
families in which a phenotype of interest is segregating
as a Mendelian trait, compatible with a single-gene de-
fect, for gene localization and identification, and the
gene’s contribution to the familial clustering of common
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Figure 1 Genetic map showing the order of markers and the
location of the PLD disease gene. Recombination intervals are in cen-
timorgans and are derived from the Ge´ne´thon map (Dib et al. 1996).
traits is then determined. We have ascertained the largest
kindred with PLD thus far investigated and have un-
dertaken a genomewide search, using a panel of highly
informative simple tandem repeats (STRs) to localize the
PLD gene to chromosome 1q21.
Material and Methods
Ascertainment of PLD families
Each kindred was ascertained independently through
one of two endocrine clinics (in Bristol and Leicester,
United Kingdom). Twenty-three members of PLDFAM1
were examined by S.J., and 30 members of PLDFAM2
were examined by J.P. and A.B. All data, including clin-
ical photographs, were reviewed by S.J. Affected status
was assigned according to the presence or absence of
subcutaneous fat in the limbs and torso, as determined
by clinical assessment of subcutaneous tissue thickness.
Eleven lipodystrophic women and seven lipodystrophic
men (age range 19–72 years) were ascertained. One 8-
year-old boy was excluded from the linkage analysis be-
cause his phenotype was unclear. This study was ap-
proved by the Leicestershire Ethics Committee.
DNA STR Polymorphism (STRP) Analysis
Peripheral venous blood (10 ml EDTA) was obtained
by venipuncture, and genomic DNA was extracted by
use of standard methods. We performed an initial ge-
nomewide search, using fluorescence-labeled primers
and semiautomated techniques to detect STRPs evenly
distributed throughout the genome at a density sufficient
to allow 190% confidence of detection of linkage in the
primary family-mapping panel. Genotypes were deter-
mined as described elsewhere (Trembath et al. 1997). In
brief, conditions for PCRwere optimized for each primer
pair over a range of annealing temperatures (50C–60C)
and magnesium concentrations (1.0–2.5 mmol MgCl2).
Amplification reactions were performed with Perkin El-
mer 9600 PCR machines.
Linkage Analysis
Linkage analysis was performed by use of the LINK-
AGE 5.1 program package (Lathrop et al. 1984) and
the FASTLINK computer program (Cottingham et al.
1993). MLINK two-point linkage analysis was per-
formed between the disease and each marker; relative
marker positions are shown in figure 1 (Dib et al. 1996).
PLD was coded as a fully penetrant autosomal dominant
trait with a gene frequency of .00001. Equal recombi-
nation frequencies between males and females were as-
sumed. A limited multipoint analysis was performed,
under the assumption of a fixed order and distance of
three loci from the region, by means of the program
VITESSE (O’Connell and Weeks 1995).
Results
Two-Point Linkage Analysis
We undertook an initial search for linkage, using the
unambiguously affected andmarried-in members of ped-
igree PLDFAM1 only (fig. 2A). From the panel of 351
STR markers, with an average intermarker separation
of 10 cM, only the marker D1S498 gave a suggestive
linkage to PLD (LOD score 3.59 at recombination frac-
tion [v] .00). Both families PLDFAM1 and PLDFAM2
were then used to test for linkage with a higher map of
additional markers spanning the region flanked by
D1S424 andD1S2762 (fig. 2A and B). Two-point LOD-
score analysis supported a locus for PLD in the region
containing markers D1S498 and D1S252. Two-point
LOD scores for these and the additional markers from
that region of chromosome 1 are summarized in table
1. A maximum combined LOD score (Zmax) of 6.89 at
was generated. Examination of the two-pointv  .00
LOD scores for each family gave no evidence of heter-
ogeneity; that is, each family showed evidence for link-
age to this region (see table 1). None of the other ge-
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Figure 2 Pedigrees of PLD kindreds. A, PLDFAM1 (above); B, PLDFAM2 (facing page). Blackened symbols represent affected individuals;
unblackened symbols represent unaffected individuals. Genotypes for microsatellite markers from chromosome 1 are shown below each symbol.
Shared haplotypes between affected individuals are boxed.
nomic regions tested for linkage gave evidence suggestive
of linkage in the primary mapping panel of patients.
Haplotype and Multipoint Analysis
To define the minimum interval containing the PLD
gene, haplotypes were constructed for each family and
were examined for evidence of recombination events (fig.
2A and B). The minimum disease-gene interval, as de-
fined by recombination between chromosome 1q21
markers and the PLD locus for each family studied, is
shown in figure 2. Obligatory recombination events
placed the disease-gene location proximal to D1S484
and distal to D1S2881, a genetic distance of 21.2 cM
(fig. 1). Using multipoint linkage analysis of three mark-
ers genotyped from the region, we obtained a maximum
LOD score of 6.6 at D1S498. The 95% confidence in-
terval (1 LOD) would place the PLD locus within a
21-cM interval flanked by D1S2881 and D1S484.
Discussion
We have localized a gene for PLD to a 21.2-cM in-
terval at chromosome 1q21 (D1S498; atZ  3.59max
). Analysis of a second PLD kindred also gavev  .00
support for linkage to this region, with a combined two-
point LOD score of 6.89 at (D1S498). Of in-v  .00
terest, detailed haplotype analysis identified a shared dis-
ease haplotype between the two families, which suggests
the segregation of a common founder mutation for PLD.
The two families investigated in this study were as-
certained independently, with PLDFAM1 residing in the
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eastern Midlands and PLDFAM2 in southwest England.
Despite detailed questioning, no common ancestor has
been identified, but it is of interest that both kindreds
are known to have originated in Ireland. Studies of ad-
ditional families with PLD will be required, to confirm
genetic homogeneity for the disease locus and to explore
the possibility of allelic association. Of importance, de-
lineation of the minimum shared interval for the disease
haplotype places the PLD gene between the markers
D1S2881 andD1S484. This region extends into the cen-
tromere of chromosome 1 and forms the boundary be-
tween a gene-dense area and the gene-sparse hetero-
chromatic region (Craig and Bickmore 1994).
Although findings for both of these families support
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Table 1
Two-Point Linkage Analysis between STRs from Chromosome 1 and PLD, for Kindreds
PLDFAM1 and PLDFAM2 and for Both Families Combined
MARKER AND
FAMILIES
LOD SCORE AT v 
Zmax : v.00 .01 .05 .1 .2 .3 .4
D1S424
PLDFAM1 4.56 1.16 .50 .24 .03 .05 .05
PLDFAM2 9.19 3.23 1.51 .82 .28 .08 .02 .03 : .4
Combined 13.74 4.39 2.01 1.06 .30 .04 .03
D1S206
PLDFAM1 8.11 .46 .72 1.05 1.06 .77 .36
PLDFAM2 1.82 1.77 1.59 1.36 .92 .53 .22 2.41 : .1
Combined 6.29 1.31 2.31 2.41 1.98 1.30 .58
D1S2651
PLDFAM1 8.27 .88 .33 .68 .77 .56 .24
PLDFAM2 .15 1.07 1.52 1.54 1.28 .86 .40 2.23 : .1
Combined 8.12 .19 1.84 2.23 2.04 1.42 .64
D1S502
PLDFAM1 3.30 .46 .72 1.05 1.06 .77 .36
PLDFAM2 .46 .53 1.01 1.07 .89 .58 .25 2.12 : .1
Combined 3.76 .07 1.73 2.12 1.96 1.35 .60
D1S2881
PLDFAM1 3.30 .46 .72 1.05 1.06 .77 .36
PLDFAM2 .15 1.07 1.52 1.54 1.28 .86 .4 2.59 : .1
Combined 3.16 .61 2.24 2.59 2.34 1.63 .75
D1S252
PLDFAM1 2.85 2.83 2.71 2.52 2.02 1.40 .68
PLDFAM2 2.78 2.72 2.46 2.14 1.48 .87 .34 5.63 : .0
Combined 5.63 5.54 5.17 4.65 3.50 2.26 1.02
D1S2696
PLDFAM1 3.59 3.53 3.28 2.96 2.26 1.51 .71
PLDFAM2 1.67 1.63 1.47 1.27 .88 .54 .25 5.26 : .0
Combined 5.26 5.16 4.75 4.23 3.15 2.05 .95
D1S498
PLDFAM1 3.59 3.53 3.28 2.96 2.27 1.51 .71
PLDFAM2 3.30 3.23 2.96 2.62 1.92 1.21 .54 6.89 : .0
Combined 6.89 6.76 6.25 5.58 4.18 2.72 1.25
D1S484
PLDFAM1 2.15 1.53 2.00 2.00 1.66 1.14 .53
PLDFAM2 2.61 .16 .68 .76 .64 .42 .19 2.77 : .1
Combined 4.76 1.69 2.68 2.77 2.30 1.56 .72
D1S2762
PLDFAM1 9.24 4.93 3.41 2.16 .95 .40 .13
PLDFAM2 2.56 2.50 2.25 1.94 1.33 .75 .27 .38 : .2
Combined 6.68 2.44 1.15 .22 .38 .35 .14
linkage to chromosome 1q21, genetic heterogeneity for
PLD may still exist. The original families described by
Kobberling appeared to have a more severe degree of
hyperlipidemia that was associated with occlusive vas-
cular disease and subsequent premature death. Linkage
analysis of surviving relatives of these and other PLD
kindreds will be required, to determine the degree of
genetic heterogeneity.
Two genes have recently been demonstrated to be ge-
netic determinants for obesity in humans (Jackson et al.
1997a; Montague et al. 1997). The endopeptidase pro-
hormone convertase 1 (PC1) is a member of a family of
precursor endoproteases that cause preferential cleavage
of both prohormones and proneuropeptides in acidic
secretary vesicles. The mechanism by which reduced ac-
tivity of PC1 leads to obesity in humans remains unclear.
Leptin is produced exclusively by adipocytes and acts
on the hypothalamic leptin receptors to both suppress
food intake and increase energy expenditure. Both in
mice and in humans, homozygous leptin mutations re-
sult in profound obesity due primarily to excessive food
intake. However, leptin does not appear to be required
for the normal intrauterine development of fat stores,
since, in leptin-deficient mice and humans, birth weights
are normal (Coleman 1979).
The reduction of subcutaneous fat stores in PLD is
apparent only after the neonatal period, which suggests
the presence of normal regional fat development during
Jackson et al.: Partial Lipodystrophy Linkage Analysis 539
intrauterine life. Genes involved in the differentiation of
preadipocytes into adipocytes or in the maintenance of
adipocyte integrity are candidates for the causative mu-
tation in this disorder. The gene encoding cellular reti-
noic acid–binding protein 2 is within the critical region
and would be expected to play a role in adipocyte dif-
ferentiation (Elder et al. 1992). Its gene product is an
intracellular binding protein with specificity for retinoic
acid and has been demonstrated to be expressed in 3T3-
L1 cells (a murine committed-preadipocyte cell line). The
role of retinoic acid is complex, and it appears to have
both permissive and inhibitory activity at different stages
of differentiation, but it has been shown to block adi-
pogenesis of 3T3-L1 cells induced to differentiate by
ectopic expression of the transcription factors PPARg
and C/EBPa (Dani et al. 1997; Schwarz et al. 1997).
Peters et al. (1998) have recently independently re-
ported linkage of the PLD gene to 1q21-22. Positional
cloning of the PLD gene will require the further refine-
ment of the minimum linkage interval. However, local-
ization of the disease to chromosomal region 1q21 rep-
resents an important step toward identification of a gene
critical in the maintenance of regional fat distribution.
The eventual characterization of the PLD gene will per-
mit assessment of its contribution to the major cardio-
vascular risk factors—namely, insulin resistance, hyper-
lipidemia, hypertension, and obesity.
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